Clinical trial
SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients…
NCT00288379 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00288379 |
|---|---|
| Title | SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma |
| Official title | A Comparative, Placebo-controlled, Double Blind, Double Dummy, Cross-over, Single Centre, Phase IIIb Study Between Formoterol Alone (Oxis® Turbuhaler® 4.5 µg) and the Fixed Combination of Formoterol and Budesonide (Symbicort® Turbuhaler®160/4.5 µg) on Airway Responsiveness and Airway Inflammation… |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | formoterol, budesonide/formoterol |
| Enrollment | 16 |
| Start date | Oct 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Feb 8, 2006 |
| Last update posted | Jan 24, 2011 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: